Cancer Biological Therapy Market

Future Market Insights

Key Insight

The cancer biological therapy market is projected to grow from USD 122.8 billion in 2025 to USD 260.2 billion by 2035, at a CAGR of 7.8%. Monoclonal Antibody Therapy will dominate with a 32.5% market share, while intravenous will lead the route of administration segment with a 45.3% share.

September 30, 2025

Anurag Sharma

250 Pages

Cite this Report

Cancer Biological Therapy Market

https://www.futuremarketinsights.com/reports/cancer-biological-therapy-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Bayer
F. Hoffmann-La Roche Ag
GSK plc
Lilly
Merck KGaA
Mylan N.V
Novartis
The Vanguard Group
L'Oréal
Sun Pharmaceutical Industries Ltd
Berkshire Hathaway

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Cancer Biological Therapy Market

Key Players

Similar Industry Reports